Monofree (Phenylephrine Hydrochloride)

Phenylephrine Hydrochloride, the active ingredient in Monofree, is an alpha‑adrenergic agonist presented as an ophthalmic solution for ocular use. It produces rapid pupil dilation and reduces conjunctival redness, facilitating eye examinations and certain surgical procedures in adult patients. The drug is marketed in the European Union and is intended for single‑dose or short‑term application under professional supervision.

GNH USA supplies Monofree as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Phenylephrine Hydrochloride acts on ocular alpha‑1 adrenergic receptors to create mydriasis and vasoconstriction, supporting several eye‑care procedures.

- Pupil dilation for ophthalmic examination: provides controlled dilation of the pupil to facilitate retinal and anterior segment evaluation. - Management of ocular redness: reduces conjunctival hyperemia by constricting superficial blood vessels. - Pre‑operative ocular preparation: aids surgical exposure by dilating the pupil before intra‑ocular procedures.

Phenylephrine hydrochloride may cause ocular and systemic reactions, most of which are mild and transient.

Common Side Effects: - Transient blurred vision: temporary difficulty focusing after administration. - Mild ocular irritation or burning sensation. - Mild headache: occasional headache due to limited systemic absorption. - Temporary increase in intra‑ocular pressure: usually resolves without intervention.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma: rapid rise in intra‑ocular pressure in susceptible eyes. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Prolonged mydriasis: pupil remains dilated longer than expected. - Systemic hypertension: elevated blood pressure from systemic absorption.

Before using Phenylephrine Hydrochloride, consider the following safety measures.

- Assess intra‑ocular pressure: avoid in patients with narrow‑angle glaucoma. - Check for hypersensitivity: discontinue if allergic reaction occurs. - Cardiovascular caution: use carefully in patients with hypertension or coronary disease. - Pediatric use: monitor closely as systemic absorption may be higher in children. - Store at room temperature: keep in original container, protect from light and moisture.

Phenylephrine Hydrochloride can interact with other medications; awareness of the interaction level helps manage risk.

Major Interactions (Avoid): - MAO inhibitors: may precipitate hypertensive crisis. - Tricyclic antidepressants: additive vasoconstrictive effect. - Beta‑blockers: may blunt ocular hypotensive response.

Moderate Interactions (Monitor Closely): - Other sympathomimetics: increased systemic adrenergic activity. - Topical ocular anesthetics: potential enhanced corneal toxicity. - Systemic antihypertensives: may reduce efficacy of blood‑pressure control.